HRAS and neoplasm: Using double immunohistochemistry for PIEZO2 and CK20 (Figure 3e), PIEZO2 and ChrA (Figure 3f), or PIEZO2 and NFP (Figure 3g–j), we observed co-localization of those proteins in a variable proportion of cells within the tumor mass.